Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acalabrutinib + Nab-Paclitaxel/Gemcitabine in Metastatic Pancreatic Cancer
NCT02570711Phase 2Terminated
- Sponsor
- Acerta Pharma
- Start
- Oct 2015
- Primary completion
- Apr 2016
- Countries
- 1
01
Overview
A Phase 2 trial of acalabrutinib tablet (Variant 1), sponsored by Acerta Pharma. Started Oct 2015; status: terminated.
02
Drugs
acalabrutinib tablet (Variant 1)
Beyond the preview
Go deeper on NCT02570711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02570711.